⌕
Sarepta Therapeutics · SRPT · Nasdaq
Tenet 48 · Mixed
Compare
$14.77−2.38%At closeTenet 48 · Mixed
$14.77−0.36 (−2.38%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Sarepta Therapeutics (SRPT) Institutional Ownership

13F filers reported holding 34.0% of Sarepta Therapeutics (SRPT) shares as of Sep 30, 2026, across 196 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
34.0%
Sep 30, 2026
13F filers
196
quarter ended Sep 30, 2026
13F value
$664.3M
36.4M shares
Quarter's fund flow
Mild distribution
21 new · 24 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds trimmed or exited than added or entered, mild distribution (21 new · 68 increased · 72 reduced · 24 closed · 11 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 196 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Sep 4, 2026Wong Ryan Ho-YanChief Financial OfficerDisposed · Tax withholding13,272$22.22↗
Sep 4, 2026Estepan Ian MichaelChief Operating OfficerDisposed · Tax withholding24,799$22.22↗
Sep 4, 2026Rothfuss CristinEVP, General CounselDisposed · Tax withholding22,025$22.22↗
Sep 4, 2026Rodino-Klapac LouisePresident, R&D and Tech OpsDisposed · Tax withholding21,423$22.22↗
Jul 28, 2026SEVERINO MICHAELChief Executive OfficerAcquired · Grant / award756,104—↗
Jul 28, 2026SEVERINO MICHAELChief Executive OfficerAcquired · Grant / award2,224,342Stock Options (right to buy)—↗
Jun 4, 2026Boor Kathryn JeandirectorAcquired · Grant / award16,875—↗
Jun 4, 2026Mayo StephendirectorAcquired · Grant / award16,875—↗
Jun 4, 2026Wigzell Hans Lennart RudolfdirectorAcquired · Grant / award16,875—↗
Jun 4, 2026BEHRENS M KATHLEENdirectorAcquired · Grant / award16,875—↗
Jun 4, 2026Connelly Deirdre PdirectorAcquired · Grant / award16,875—↗
Jun 4, 2026Nicaise ClaudedirectorAcquired · Grant / award16,875—↗
Jun 4, 2026Chambers Michael AndrewdirectorAcquired · Grant / award16,875—↗
Jun 4, 2026Barry RicharddirectorAcquired · Grant / award16,875—↗
Mar 12, 2026Mayo StephendirectorDisposed · Open-market sale7,239$17.02↗
Mar 11, 2026Estepan Ian MichaelChief Operating OfficerDisposed · Tax withholding1,097$17.03↗
Mar 11, 2026Wong Ryan Ho-YanChief Financial OfficerDisposed · Tax withholding256$17.03↗
Mar 11, 2026Rodino-Klapac LouisePresident, R&D and Tech OpsDisposed · Tax withholding948$17.03↗
Mar 11, 2026Rothfuss CristinEVP, General CounselDisposed · Tax withholding974$17.03↗
Mar 9, 2026Wong Ryan Ho-YanChief Financial OfficerDisposed · Tax withholding162$16.95↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Sarepta Therapeutics do institutions hold?

13F filers reported holding 34.0% of Sarepta Therapeutics' shares as of Sep 30, 2026, across 196 filers.

How many 13F filers hold Sarepta Therapeutics?

Sarepta Therapeutics was held by 196 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.